Swedish Orphan Biovitrum’s Acquisition of CTI BioPharma

Skadden and Gibson, Dunn & Crutcher acted as legal advisor on the transaction. CTI BioPharma (Nasdaq: CTIC) (“CTI”) entered into a definitive agreement under which Swedish Orphan…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now